📊 Score Breakdown
Offering Ability
70
Cash Runway
0
Float Risk
25
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
26%
📉 Score Deterioration
40%
• Score rose 20 points recently (worsening)
💰 Capital Raise
20%
• Active shelf registration ($200M, 87% of market cap)
💹 Market Data
Market Cap$228.75M
Shares Outstanding46.59M
Float30.87M
Cash$78.06M
Debt$60.00M
Short InterestN/A
🏛 Institutional Holdings
30 institutional holders · 23.07M shares
#1
FEDERATED HERMES, INC.
5.37M shares
#2
Vivo Capital, LLC
4.32M shares
#3
Logos Global Management LP
3.31M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest1.19M
Days to Cover10.7
% of Float3.8%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Dec 31, 2025
xbrl
XBRL CONVERTIBLE
Dec 31, 2025
4
INSIDER TRANSACTION
Apr 01, 2026
EFFECT
EFFECT
Mar 19, 2026
S-3
SHELF
Mar 11, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for NERV
📊 NERV FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 NERV Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.